Elevated Circulating Pigment Epithelium-Derived Factor Predicts the Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes

被引:52
作者
Hui, Elaine [1 ,2 ]
Yeung, Chun-Yip [1 ]
Lee, Paul C. H. [1 ]
Woo, Yu-Cho [1 ]
Fong, Carol H. Y. [1 ]
Chow, Wing-Sun [1 ]
Xu, Aimin [1 ,2 ,3 ]
Lam, Karen S. L. [1 ,2 ,3 ]
机构
[1] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Res Ctr Heart Brain Hormones & Hlth Aging, Pokfulam, Hong Kong, Peoples R China
[3] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Pokfulam, Hong Kong, Peoples R China
关键词
FACTOR PEDF; INSULIN-RESISTANCE; PLASMA-CONCENTRATION; METABOLIC SYNDROME; KIDNEY-FUNCTION; DISEASE; MARKER; LEVEL; ADIPOCYTES; CREATININE;
D O I
10.1210/jc.2014-2235
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Pigment epithelium-derived factor (PEDF), a circulating glycoprotein with antiangiogenic, antioxidative, and anti-inflammatory properties, protects against diabetic nephropathy (DN) in animal models. Objective: We investigated whether circulating PEDF predicted the progression of DN in a 4-year prospective study. Design, Setting, and Participants: Baseline plasma PEDF levels were measured in type 2 diabetic subjects recruited from the Hong Kong West Diabetes Registry. The role of PEDF in predicting chronic kidney disease (CKD) and albuminuria progression was analyzed using Cox regression analysis. Main Outcome Measure: We evaluated CKD progression, defined as deterioration in CKD staging and a 25% or greater drop in estimated glomerular filtration rate (eGFR) according to International Society of Nephrology statements. Results: At baseline, plasma PEDF levels increased progressively with CKD staging (P for trend <.001; n = 1136). Among 1071 subjects with baseline CKD stage <= 3, plasma PEDF levels were significantly higher in those with CKD progression(n = 171) during follow-up than those without(P < .001). Baseline PEDF was independently associated with CKD progression (hazard ratio = 2.76; 95% confidence interval = 1.39-5.47; P = .004), adjusted for age, sex, waist circumference, diabetes duration, hemoglobin A1c, systolic blood pressure, use of antihypertensive drugs, C-reactive protein, and eGFR. Elevated baseline PEDF was also associated with the development of microalbuminuria/albuminuria in a subgroup with normoalbuminuria and eGFR > 60 mL/min/1.73 m(2) (n = 462) at baseline (hazard ratio = 2.75; 95% confidence interval = 1.01-7.49; P < .05), even after adjustment for potential confounders. Conclusions: Elevated PEDF levels may represent a compensatory change in type 2 diabetic patients with renal disease and appear to be a useful marker for evaluating the progression of DN.
引用
收藏
页码:E2169 / E2177
页数:9
相关论文
共 38 条
  • [31] One-Year Change in Kidney Function Is Associated with an Increased Mortality Risk
    Turin, Tanvir Chowdhury
    Coresh, Josef
    Tonelli, Marcello
    Stevens, Paul E.
    de Jong, Paul E.
    Farmer, Christopher K. T.
    Matsushita, Kunihiro
    Hemmelgarn, Brenda R.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2012, 36 (01) : 41 - 49
  • [32] Serum pigment epithelium-derived factor levels are independently correlated with the presence of coronary artery disease
    Wang, Feifei
    Ma, Xiaojing
    Zhou, Mi
    Pan, Xiaoping
    Ni, Jie
    Gao, Meifang
    Lu, Zhigang
    Hang, Jingyu
    Bao, Yuqian
    Jia, Weiping
    [J]. CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [33] Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy
    Wang, JJ
    Zhang, SX
    Lu, KM
    Chen, Y
    Mott, R
    Sato, S
    Ma, JX
    [J]. DIABETES, 2005, 54 (01) : 243 - 250
  • [34] Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy
    Wang, Joshua J.
    Zhang, Sarah X.
    Mott, Robert
    Chen, Ying
    Knapp, Ryan R.
    Cao, Wei
    Ma, Jian-xing
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 294 (05) : F1166 - F1173
  • [35] Salutary effect of pigment epithelium-derived factor in diabetic nephropathy - Evidence for antifibrogenic activities
    Wang, Joshua J.
    Zhang, Sarah X.
    Mott, Robert
    Knapp, Ryan R.
    Cao, Wei
    Lau, Kai
    Ma, Jian-xing
    [J]. DIABETES, 2006, 55 (06) : 1678 - 1685
  • [36] Positive association of circulating levels of advanced glycation end products (AGEs) with pigment epithelium-derived factor (PEDF) in a general population
    Yamagishi, Sho-ichi
    Matsui, Takanori
    Adachi, Hisashi
    Takeuchi, Masayoshi
    [J]. PHARMACOLOGICAL RESEARCH, 2010, 61 (02) : 103 - 107
  • [37] Pigment epithelium-derived factor (PEDF) ameliorates advanced glycation end product (AGE)-induced hepatic insulin resistance in vitro by suppressing Rac-1 activation
    Yoshida, T.
    Yamagishi, S.
    Nakamura, K.
    Matsui, T.
    Imaizumi, T.
    Takeuchi, M.
    Koga, H.
    Ueno, T.
    Sata, M.
    [J]. HORMONE AND METABOLIC RESEARCH, 2008, 40 (09) : 620 - 625
  • [38] Yu JY, 2010, DIABETES RES CLIN PR, V87, P157, DOI [10.1016/j.diabres.2009.11.002, 10.1016/j.diabres.2009.12.005]